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Abstract 
The cytokine BAFF binds to the receptors TACI, BCMA and BAFF-R on B cells, 
whereas APRIL binds to TACI and BCMA only. 
The signaling properties of soluble trimeric BAFF (BAFF 3-mer) were compared 
to those of higher order BAFF oligomers. All forms of BAFF bound BAFF-R and TACI, 
and elicited BAFF-R-dependent signals in primary B cells. In contrast, signaling through 
TACI in mature B cells or plasmablasts was only achieved by higher order BAFF and 
APRIL oligomers, all of which were also potent activators of a multimerization-
dependent reporter signaling pathway. These results indicate that although BAFF-R and 
TACI can provide B cells with similar signals, only BAFF-R, but not TACI, can respond 
to soluble BAFF 3-mer, which is the main form of BAFF found in circulation. BAFF 60-
mer, an efficient TACI agonist, was also detected in plasma of BAFF transgenic and non-
transgenic mice and was greater than 100-fold more active than BAFF 3-mer for the 
activation of multimerization-dependent signals. TACI supported survival of activated B 
cells and plasmablasts in vitro, providing a rational basis to explain the immunoglobulin 
deficiency reported in TACI-deficient individuals.  
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Introduction 
B-cell activating factor of the TNF family (BAFF, also known as BLyS) and A 
Proliferation-Inducing Ligand (APRIL) are two members of the TNF family mainly 
involved in B cell physiology (reviewed in 1-3). BAFF is expressed by myeloid cells and 
by unidentified radiation-resistant cells, possibly stromal cells of secondary lymphoid 
organs 4-6. BAFF is either expressed at the cell surface or released into a soluble form 
through cleavage by an uncharacterized furin 7-9. Members of the TNF family usually 
assemble as trimers 10, but soluble BAFF was crystallized both as a trimer and as a virus-
like structure resulting from the ordered assembly of twenty trimers through an unusually 
long loop of BAFF between β-sheets D and E (DE loop) 11,12. Although the physiological 
relevance of BAFF 60-mer has not been studied, recent work showed that BAFF 60-mer 
was also produced by cells expressing BAFF endogenously, and that the 60-mer was 
moderately more potent than the 3-mer at co-stimulating BCR-induced thymidine uptake 
in primary B cells 13. APRIL, a close homologue of BAFF, can also co-stimulate B cells 
but requires oligomerization in order to do so 14.  
BAFF and APRIL share two receptors, namely TACI (transmembrane activator and 
CAML interactor) and BCMA (B cell maturation antigen). In addition, BAFF binds to a 
third receptor, BAFF-R, also known as BR3. The role of BAFF in peripheral B cell 
development is well recognized. B cells are generated in the bone marrow, which they 
exit at an immature stage. Subsequent maturation takes place in the spleen, where B cells 
evolve through the transitional T1 and T2 stages to mature follicular B cells or marginal 
zone B cells. Encounter with antigen leads to B cell activation and differentiation into 
TACI requires oligomerized ligands  Bossen et al. Page 4 
memory B cells or antibody secreting plasmocytes, whose survival in the bone marrow 
requires BAFF and/or APRIL 14,15. 
In BAFF-deficient mice, the reduced expression of CD21 and CD23 by B cells was 
initially interpreted as a blockade at the T1 stage, but it was shown later that subsequent 
maturation steps also occurred in BAFF-deficient mice, but at reduced frequency 16. This 
finding is in line with the broad survival function of BAFF described for both transitional 
and mature B cells 17,18, and with the fact that BAFF can be functionally replaced by 
enforced expression of the anti-apoptotic factor Bcl-2 in B cells, further pointing to its 
prosurvival function 19. BAFF-R-deficiency recapitulates most of the phenotype of 
BAFF-deficient mice, but affects T-dependent and T-independent humoral responses less 
severely 20, suggesting that although BAFF-R transmits important BAFF signals, there 
are other functional receptors for BAFF in vivo.  
The role of APRIL in B cell physiology is less well established. One strain of APRIL-
deficient mice had lowered IgA serum levels and impaired mucosal IgA responses 21 that 
were not observed in a second APRIL-deficient strain 22. Reduced IgA serum levels are 
also characteristic of TACI-deficient mice, indicating that APRIL might mediate IgA 
class switch, or survival of switched IgA-secreting cells, through TACI 23. TACI is 
generally perceived as a negative regulator of B cells because TACI-/- mice have an 
enlarged B cell pool that may be linked to autoimmune manifestations 23,24. TACI-
deficient mice are also characterized by reduced antibody responses to T-independent 
antigens, a feature that is also observed in BAFF-deficient mice 20,23. Interestingly, about 
10% of patients with common variable immunodeficiency (CVID) have mutations in 
TACI, suggesting a role for TACI in the production of antibodies of various isotypes 25,26.  
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The third receptor, BCMA, is apparently dispensable for early B cell differentiation 
stages, but likely plays a role for long-term maintenance of bone marrow plasma cells 15. 
To date, the signaling impact of ligand oligomerization has not been investigated in these 
systems. Here, we studied the ability of BAFF 3-mer and higher order oligomers to signal 
through BAFF-R and TACI in primary mouse B cells. In contrast to BAFF-R, TACI was 
unresponsive to BAFF 3-mer, yet provided survival and differentiation signals when 
triggered by oligomeric forms of BAFF or APRIL. BAFF 60-mer is one form of 
oligomeric BAFF that can activate TACI and that exists naturally in vivo. 
 
Materials and Methods 
Mice, cell lines and reagents: 
C57/Bl6 mice, 6- to 8-week-old were obtained from Harlan. TACI-/-, BCMA-/-, TACI-/- x 
BCMA-/- 20 and BAFF transgenic mice 27 have been described previously. Mice were 
handled according to institutional and Swiss Federal Office guidelines, as well as under 
the authorization of the Veterinarian Service of Canton de Vaud.  
Jurkat-BCMA:Fas cells (Jurkat-2309 clone 13) were generated as described in 
supplemental material. Myc-BAFF, BAFF H218A, BAFF A134 and BAFF N242Q, Flag-
BAFF, BCMA-Fc, TACI-Fc and BAFF-R-Fc have been described previously 13,28. Flag-
tagged APRIL containing aa 92-233 of human APRIL was purified from supernatants of 
transiently transfected 293T cells (see supplemental material). The hamster mAb B9C11 
anti-mouse BAFF-R was kindly provided by Dr Melissa Starovasnik (Genentech, San 
Francisco). Commercial reagents were as follow: rat IgM Buffy-2 anti-human BAFF, rat 
IgG1 5A8 anti-mouse BAFF and rat IgG1 1C9 anti-mouse BAFF (Alexis), anti-Flag M2 
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mAb and biotinylated M2 mAb (Sigma), carboxy fluorescein diacetate succinimide ester 
(CFSE) (Molecular Probe), mouse IL-4 and mouse IL-6 (PeproTech). 
 
Cytotoxicity assay: 
The cytotoxicity assay using BCMA:Fas Jurkat cells was performed as described for 
FasL on Jurkat cells 29. When stated, the assay was performed in the presence of 1.5 
µg/ml of cycloheximide to increase susceptibility of the cells to apoptosis. In some 
instances, BCMA-Fc was added at a final concentration of 2.5 µg/ml to assess the 
specificity of the assay. 
For membrane-bound BAFF, 293T cells were transfected with an uncleavable form of 
full length mouse BAFF (R125A and R126A) and incubated for 16 h with a fixed number 
of Jurkat BCMA:Fas target cells and various ratio of effector cells. Cell death was 
assessed by FACS, based on the FSC/SSC profile that allows discriminating 293T cells 
from live Jurkat cells from dead Jurkat cells. To monitor BAFF in transfected 293T cells, 
cells were lysed in 20 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% Triton-X100, 
CømpleteTM protease inhibitor cocktail (Roche), and BAFF was quantified in the lysate 
by ELISA (see supplemental material). 
 
Gel permeation chromatography: 
293T cells were transiently transfected with a full-length mouse BAFF cDNA and grown 
for 7 days in carbonate-buffered medium. Cell supernatants or mouse plasma (200 µl) 
were fractionated by gel filtration on Superdex-200 as previously described 13 and 
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analyzed by Western blotting using Buffy-2 mAb, or by ELISA (see supplemental 
material). Fractions were also tested for their ability to kill Jurkat BCMA:Fas cells.  
 
Characterization of ligand - receptor interactions:  
Immunoprecipitation of TACI-Fc with Protein A-Sepharose followed by Western blot 
analysis, and detection of ligand-receptor interactions by ELISA were performed 
according to standard techniques (see supplemental material).  
 
Splenocyte survival, co-stimulation and MHC class II upregulation assays: 
A detailed protocol is provided in the supplemental material. Briefly, B220-purified B 
cells were grown for 66 h in the presence of ligands, anti-Flag and anti-BAFF-R 
antibodies as required. Viable cells were identified based on the FSC/SSC profile. B cell 
proliferation in response to an anti-mouse µ chain F(ab')2  antibody was monitored by 
thymidine incorporation. In some experiments, B cells were stained with CFSE prior to 
cultivation. MHC class II upregulation was monitored by FACS analysis. 
 
Ig production assay: 
Purified splenic B cells (106/well in 1ml of complete RPMI, 24-well plates) were grown 
for 6 days in the presence of the different ligands at 100 ng/ml. When specified, IgA+ B 
cells were depleted by incubation with biotinylated goat anti-mouse IgA (1:500; Caltag) 
for 10 minutes at 4°C followed by streptavidin-conjugated magnetic beads (Miltenyi 
Biotech). IgA and IgM titers in culture supernatants were quantified by ELISA (see 
supplemental material).  
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Plasmablasts survival assays: 
10- to 12-week-old mice were injected s.c. into hind footpads with 107-108 MMTV 
particles in infected milk 30. MMTV (SW) encodes a Vβ6-specific superantigen. 
Synchronized plasmablasts were isolated from the draining popliteal lymph nodes 6 days 
after infection, and purified with PE-conjugated anti-mouse CD138 (Becton Dickinson) 
and anti-PE magnetic beads (Miltenyi Biotech). Purified plasmablasts (105/well in 200 µl 
of complete RPMI) were incubated for 44 hours with different ligands at 500 ng/ml. 
Number of viable plasmablasts were analyzed by IgG2a/c ELISPOT (see supplemental 
material).   
Survival of CD138+, tetanus toxoid-specific splenic plasmablasts, obtained at the peak of 
a booster response, was measured in the presence or absence of various BAFF and 
APRIL proteins, essentially as described 31,32. See also supplemental material.  
 
Results 
Natural and engineered BAFF oligomers are more potent than BAFF 3-mer at delivering 
multimerization-dependent signals. 
Some TNF family ligands are not biologically active as soluble trimers, but gain activity 
when oligomerized by fusion with the Fc portion of an immunoglobulin, or by addition of 
cross-linking antibodies, thereby mimicking the membrane-bound form of the ligand 29,33. 
It is not known whether the activity of BAFF is conditioned by its level of 
oligomerization, such as those found in BAFF 3-mer and BAFF 60-mer 13,34. In order to 
monitor the activity of BAFF 3-mer and oligomers, a surrogate cell death assay was 
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developed, in which the oligomerization-dependent apoptotic Fas pathway can be 
initiated by BAFF. For this purpose, a fusion protein consisting of the extracellular 
domain of BCMA fused to the transmembrane and intracellular domains of Fas was 
expressed in Jurkat T cells. Clones that underwent apoptosis in response to BAFF were 
selected. Ligands tested included BAFF 3-mers (myc-BAFF, Flag-BAFF and BAFF with 
mutation H218A preventing 60-mer formation) and various BAFF oligomers (i.e. 
containing two or more BAFF 3-mers within the same complex) such as Fc-BAFF, Flag-
BAFF plus anti-Flag, or BAFF 60-mers (BAFF starting at the natural processing site 
A134, with or without mutation N242Q that prevents N-glycosylation. See suppl. figure 
1). Stimulation of Jurkat BCMA:Fas cells revealed that all BAFF oligomers were two to 
three orders of magnitude more potent than BAFF 3-mers at inducing cell-death through 
the surrogate, multimerization-dependent Fas signaling pathway (Figure 1A).  
In order to determine whether membrane-bound BAFF can trigger a multimerization-
dependent pathway, a non-cleavable form of full length BAFF with mutations R125A 
and R126A in the furin-processing site was generated (Suppl. figure 2). Cells expressing 
non-cleavable membrane-bound BAFF were at least 50-fold more active than soluble 
BAFF 3-mer on BCMA:Fas Jurkat cells, indicating that membrane-bound BAFF can 
indeed be assimilated to an oligomeric ligand (Figure 1B). Membrane-bound BAFF was 
apparently less active that soluble BAFF 60-mer in this assay (Figure 1B), possibly 
because only a fraction of membrane-bound BAFF is expressed at the cell surface.  
In order to determine whether initiation of productive signaling through unmodified 
BCMA was also sensitive to BAFF oligomerization, BCMA-transfected 293T cells were 
exposed to BAFF 3-mer or BAFF 60-mer, and monitored for the activation of a NF-κB 
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reporter system. In this assay, BAFF 60-mer readily induced a robust, BCMA-dependent 
NF-κB signal, whereas BAFF 3-mer was roughly 1000-fold less active (Suppl. figure 3). 
The difference between BAFF 3-mer and BAFF 60-mer observed in both assays could 
not be accounted for by differential binding to the receptor, as both proteins bound TACI-
Fc in immunoprecipitation experiments (Figure 1C) and similarly bound BCMA, TACI 
and BAFF-R in an ELISA assay (Figure 1D). Only BAFF N242Q displayed a 
comparatively reduced affinity (Figure 1D), that probably explains why it was somewhat 
less active than BAFF A134 (Figure 1A). 
These results indicate that BAFF oligomers, including membrane-bound BAFF and 
BAFF 60-mer, are activators of multimerization-dependent signaling pathways. 
 
The anti-mouse BAFF-R antibody B9C11 antagonizes BAFF-BAFF-R signals. 
Receptor-deficient mice were used to study the impact of ligand oligomerization on 
BAFF-R and TACI signaling in primary B cells. However, instead of using BAFF-R-/- B 
cells that are not only scarce but also immature, BAFF-R-expressing B cells were treated 
with a blocking anti-BAFF-R antibody (B9C11). Despite a weak agonist activity, B9C11 
completely abrogated the pro-survival effects of Myc-BAFF (3-mer), BAFF H218A (3-
mer) and BAFF N242Q (60-mer), and also antagonized the pro-survival effects of BAFF 
A134 (60-mer) at concentrations below 20 ng/ml (Figure 2M-P). Thus, B9C11 prevents 
BAFF signaling through BAFF-R, and can therefore be used to discriminate BAFF 
signals delivered through BAFF-R from those given through TACI and/or BCMA. 
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BAFF 3-mer, BAFF oligomers and APRIL co-stimulate B cells through distinct sets of 
receptors that respond differentially to ligand oligomerization. 
The ability of BAFF 3-mers and oligomers to co-stimulate thymidine incorporation in 
BCR-stimulated primary B cells was tested in vitro. For this purpose, ligands were 
titrated on purified B splenocytes of wild type, BCMA-/-, TACI-/- and BCMA-/- x TACI-/- 
mice, in the presence of stimulating anti-IgM antibodies and with or without addition of 
the B9C11 anti-BAFF-R antibody at a blocking concentration. Previous work 
demonstrated that anti-IgM stimulation upregulates TACI in these BAFF-R positive cells 
35
. Because APRIL binds to TACI and BCMA, but not to BAFF-R, recombinant Flag-
tagged APRIL was also tested, in the presence or absence of cross-linking anti-Flag 
antibody 14. We selected human APRIL because it does not bind at all to murine BAFF-
R, in contrast to mouse APRIL 36. 
Thymidine incorporation in BCR-stimulated wild type B cells was co-stimulated in a 
dose-dependent manner by BAFF 3-mer, BAFF 60-mer and cross-linked APRIL (Figure 
2A, B, Q). Although CFSE-labelled cells underwent division in response to anti-BCR 
stimulation, co-stimulation with BAFF or cross-linked APRIL increased the number of 
viable cells without affecting the division pattern (Suppl. figure 4). BAFF also enhanced 
B cell survival in the absence of B cell receptor stimulation (Suppl. Figure 4). These 
results suggest that the increased thymidine incorporation mediated by BAFF and APRIL 
co-stimulation is due mainly, if not entirely, to increased B cell survival.  
APRIL-mediated effects were entirely TACI-dependent and insensitive to the presence of 
the B9C11 anti-BAFF-R antibody (Figure 2S, U, V). In contrast, the survival effect of 
BAFF 3-mer was abrogated in the presence of B9C11, irrespective of the presence or 
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absence of TACI and BCMA (Figure 2M, O). Thus, the same biological outcome, B cell 
survival, was mediated through BAFF-R in response to BAFF 3-mer, and through TACI 
in response to cross-linked APRIL. 
The survival effects of BAFF 60-mers were only reduced by the blocking anti-BAFF-R 
antibody or by TACI deficiency in isolation, but was abrogated by the combination of 
both, demonstrating that BAFF 60-mer activated both BAFF-R and TACI (Figure 2A, G 
K, M). Interestingly, TACI signals were only induced by oligomeric ligands, i.e. BAFF 
60-mer or cross-linked APRIL, but not by Flag-tagged APRIL or two different BAFF 3-
mers. In contrast, BAFF-R signals were triggered by both BAFF 3-mer and BAFF 60-
mer. 
In addition to BAFF 60-mer and cross-linked APRIL, TACI signalling was also 
efficiently triggered by Fc-BAFF and cross-linked Flag-BAFF, but not by Flag-BAFF 
alone, indicating that TACI responds to oligomeric, but not trimeric ligands 
(Suppl. figure 5). Moreover, signalling of BAFF N242Q (60-mer) through TACI 
could be inhibited in a dose-dependent manner by an excess of BAFF H218A (3-
mer) (Suppl. Figure 6). 
Taken together, these results indicate that co-stimulation of BCR-stimulated B cells 
results from increased cell survival rather than increased cell proliferation, and that 
different ligands functionally engage different sets of receptors: BAFF 3-mer signals 
through BAFF-R only, cross-linked APRIL through TACI only, and BAFF 60-mer 
through both BAFF-R and TACI, the latter receptor responding to oligomeric ligands 
only. BCMA was not involved in B cell co-stimulation. 
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TACI-mediated, but not BAFF-R-mediated MHC class II upregulation requires 
oligomeric ligands. 
Murine B cells treated with IL-4 and IL-6 upregulate MHC class II molecules and can 
present antigens in response to APRIL 37. MHC class II was upregulated in B cells not 
only in response to cross-linked APRIL, but also in response to BAFF 3-mer and BAFF 
60-mer, but not Flag-APRIL alone (Figure 3). The effect of APRIL was TACI-
dependent, whereas that of BAFF 3-mer and BAFF 60-mer was also seen in B cells 
expressing BAFF-R only (Figure 3). Blocking of BAFF-R with B9C11 completely 
abrogated the activity of Myc-BAFF (3-mer) and Flag-BAFF (3-mer), but only reduced 
that of cross-linked BAFF, Fc-BAFF and BAFF 60-mer, indicating that BAFF oligomers 
can also signal MHC class II upregulation through TACI (Suppl. figure 7). Thus, as 
shown above for B cell co-stimulation, ligand-mediated upregulation of MHC class II in 
B cells can be mediated by BAFF-R and TACI, the latter receptor responding to 
oligomeric ligands. BCMA was not required for MHC class II upregulation. 
Increased immunoglobulin production by B splenocytes and plasmablast survival require 
TACI and oligomerized ligands. 
BAFF and APRIL enhance immunoglobulin production in in vitro cultures of purified B 
splenocytes 21. IgM production in supernatants of B splenocytes cultured for six days was 
increased 3- and 6-fold in response to cross-linked APRIL and BAFF 60-mer, 
respectively, an effect that was mainly mediated by TACI (Figure 4A). In contrast, BAFF 
3-mer only induced a modest, BAFF-R-dependent response. Although IgA secretion 
paralleled that of IgM in this assay, this was the result of increased survival of pre-
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existing IgA-positive cells rather than isotype switch (data not shown). We conclude that 
increased IgM and IgA production in this assay was predominantly mediated by TACI in 
response to oligomerized ligands, with a possible marginal contribution of BAFF-R.  
Increased immunoglobulin production can result from either enhanced Ig secretion and/or 
from a higher number of Ig-secreting cells. In order to specifically address the survival 
effect of BAFF and APRIL on antibody secreting cells, mice were infected with mouse 
mammary tumor virus (MMTV) and synchronized plasmablasts were isolated from the 
draining lymph node six days post-infection 30. Alternatively, mice were immunized with 
tetanus toxoid, and plasmablasts were isolated from spleens at the peak of the booster 
response. Purified plasmablasts were cultured for two days in vitro, in the presence or 
absence of BAFF or APRIL, and the number of viable, antibody secreting cells was 
quantified by ELISPOT. Under these conditions, numbers of antibody secreting cells 
were increased 6- to 10-fold in response to BAFF 60-mer or cross-linked APRIL (Figure 
4B and C). This effect was impaired in TACI-deficient cells and, to a lesser extent, in 
BCMA-deficient cells, and was completely abrogated in cells deficient for both TACI 
and BCMA, indicating that TACI and BCMA, but not BAFF-R, contribute to plasmablast 
survival. BAFF 3-mer and Flag-APRIL displayed weaker activity than their oligomerized 
counterparts on responsive B cells, in line with the idea that TACI, and possibly BCMA, 
require oligomerized ligands. In summary, we conclude that plasmablast survival is 
enhanced by oligomeric BAFF and APRIL in a TACI- and possibly BCMA-dependent 
manner. 
Formation of 60-mers is a property of both human and mouse BAFF. 
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If oligomerization of BAFF in the form of a 60-mer were a physiologically relevant 
feature, as suggested by its specific ability to trigger TACI-dependent responses, it would 
be expected to be conserved across species. The extended DE loop of BAFF, also known 
as the "flap" region 12, is not found in other TNF family members but its length is 
precisely conserved in BAFF of fishes, batrachians, birds and mammals (Figure 5A). 
Moreover, all residues involved in trimer-trimer interaction, including the histidine 
residue responsible for pH-dependent assembly of the 60-mer 12,13, are conserved in 
human, mouse, opossum (marsupial), platypus (monotreme), chicken and 10 further bird 
and mammalian BAFFs (Figure 5A and data not shown). 
It has been previously demonstrated that addition of a short N-terminal Myc tag to 
soluble BAFF prevents 60-mer formation 13. Because murine BAFF contains an 
additional exon encoding 31 amino acid residues close to the mature N-terminus of 
soluble BAFF 9 (Suppl. figure 1), it is questionable whether mouse BAFF can form 60-
mer at all. However, supernatants of 293T cells transfected with full length mouse BAFF 
contained, in addition to BAFF 3-mer, a fair proportion of a high molecular weight (> 
600 kDa) form of processed mouse BAFF, suggesting that it was able to form 60-mers. 
This conclusion was reinforced by the observation that murine BAFF 60-mer was acid-
sensitive and, therefore, no longer detected when analyzed at pH 5 (Figure 5B). We 
conclude that the formation of a 60-mer is an evolutionarily conserved property of BAFF. 
 
Circulating BAFF 60-mer in BAFF transgenic mice and TACI-/- mice is a major provider 
of oligomerization-dependent signals.  
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Although BAFF 60-mer has been previously found in supernatants of human U937 cells 
13
, it has never been described in ex vivo samples. For the purpose of detecting BAFF 60-
mer in vivo, plasma of BAFF transgenic mice that express full length mouse BAFF under 
the α1-anti-trypsin promoter 27 was size-fractionated by gel permeation chromatography, 
and analyzed for its BAFF content by ELISA and for its oligomerization-dependent 
activity with Jurkat BCMA:Fas cells. Although the majority of BAFF eluted with a size 
of about 60 kDa (BAFF 3-mer), about 4% of the BAFF protein eluted at a size of about 
1000 kDa, compatible with that of BAFF 60-mer, and accounted for two thirds of the 
total oligomerization-dependent activity (Figure 6A). The activity of this peak was totally 
abrogated by a soluble decoy receptor and displayed acid sensitivity, further suggesting 
that it was due to BAFF 60-mer (Figure 6A and data not shown). In line with these 
results, BAFF 3-mer isolated from plasma of BAFF transgenic mice induced a robust, 
B9C11-inhibitable survival response in wild type B cells, whereas the more diluted 
BAFF 60-mer also induced a specific response, but of lower intensity (data not shown). 
BAFF 60-mer was then sought in mice that are not transgenic for BAFF. As the Fas 
pathway used in the bioassay is inhibited by short-lived proteins such as FLIP, its 
sensitivity can be increased by inhibitors of protein synthesis 38. Indeed, cycloheximide 
increased the detection limit of the assay about 10-fold (Suppl. figure 8), but this 
remained insufficient to detect the activity of a putative BAFF 60-mer in the plasma of 
wild type mice (Figure 6B). However, under these conditions, BAFF 60-mer was readily 
detected in the plasma of TACI-/- mice that display about 10-fold elevated circulating 
BAFF levels compared to wild type mice (Figure 6C).  
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An additional activity peak of intermediate size and of higher specific activity than BAFF 
3-mer was detected in both BAFF transgenic and TACI-/- mice, but was not further 
characterized (Figure 6A and C). 
We conclude from these experiments that several forms of soluble BAFF are found in the 
plasma of BAFF transgenic and non-transgenic mice, including a low-abundance but 
highly active BAFF 60-mer. 
 
Discussion 
One of most striking finding of this study is the differential ability of BAFF-R and TACI 
to signal in response to their common ligand BAFF. Although both receptors bind BAFF 
with high affinity (reviewed in 1), BAFF-R responded to both BAFF trimers and higher 
order BAFF oligomers, whereas TACI showed a strict specificity for the latter. This 
differential signaling behavior was consistently observed in several assays involving B 
cells at various stages of differentiation, even if the final outcome of the signaling 
pathways, such as cell survival of upregulation of surface markers, was the same for both 
receptors. 
What are the physiological forms of BAFF that can signal through TACI? An obvious 
candidate is the membrane-bound form of BAFF that has been identified on myeloid cells 
7,8
. Thus, productive signaling through TACI may require cell-cell contacts, ensuring that 
the signal is delivered at specific sites, and not in a systemic manner. BAFF-R, in 
contrast, may also respond to soluble BAFF 3-mer which represent the vast majority of 
systemic BAFF. This situation is reminiscent of TNF-R2 that responds to membrane-
bound TNF and TNF-R1 that responds to both membrane-bound and trimeric soluble 
TACI requires oligomerized ligands Bossen et al. Page 18 
TNF 39. Another candidate activator of TACI signals is BAFF 60-mer, an oligomeric 
form of BAFF known from crystallographic studies 12,34,40, but for which little or no 
information exist regarding the function and occurrence in vivo. Our study brings about 
important new elements pointing to possible physiological implications of BAFF 60-mer. 
First, BAFF 60-mer formation is evolutionarily conserved. Second, an active form of 
BAFF 60-mer is found in plasma of BAFF transgenic mice, but also in plasma of mice 
such as TACI-/- with an un-manipulated BAFF gene. Third, BAFF 60-mer and BAFF 3-
mer activate different sets of receptors and can therefore be considered as distinct ligands. 
The originality of BAFF when compared to membrane-bound and soluble TNF is its 
unique mode of oligomerization as a virus-like particle, its pH-sensitive nature, and the 
ability to mimic a membrane-bound form of the ligand in a soluble form.   
How is it possible to explain that TACI and BAFF-R have different requirements for 
ligand oligomerization? This may reflect receptor-specific mechanisms of intracellular 
signaling. TACI binds TNF receptor associated factors (TRAFs) on its intracellular 
domain (reviewed in 1). TRAFs are trimeric intermediates in the signaling pathway of 
numerous TNF receptor family members 41. By bringing together three receptors, a 
trimeric ligand may allow recruitment to the complex of just one intracellular TRAF, 
which may not be enough to induce signaling, as oligomerization of trimeric TRAF-2 and 
TRAF-6 is required to activate downstream signaling events 42. BAFF-R only interacts 
with TRAF-3, whose mode of action and multimerization requirements may be distinct, 
making BAFF-R-mediated signals less dependent on ligand oligomerization. 
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Beside promoting survival, BAFF and APRIL also induced upregulation of activation 
markers such as MHC class II, in line with the enhanced MHC class II expression found 
in B cells of BAFF transgenic mice at various maturation stages 27. Although BCMA was 
reported to induce MHC class II upregulation in IL4- and IL6-stimulated A20 cells 37, our 
results demonstrate that MHC class II expression in primary B splenocytes can also be 
stimulated by BAFF-R and TACI signals, and that stimulation with IL4 and IL6 was not 
essential for this outcome. 
It is well documented that BAFF-R induces B cell survival, and BCMA is strongly 
suspected to promote survival of long-lived plasma cells 15,43. However, in contrast to 
BAFF-R and BCMA, TACI is generally described as a negative regulator of B cell 
survival because TACI-deficient mice have an enlarged B cell pool 23,24, and because an 
engineered cell line expressing an EDA receptor:TACI chimera could be killed with EDA 
24
. In addition, agonist anti-TACI antibodies inhibited proliferation of a B cell line 24, and 
anti-TACI antibodies prevented Ig secretion in BAFF-R- or CD40-stimulated B cells 24,44. 
How can these results be reconciled with our observation that TACI only mediated 
"positive" events such as survival of primary B cells in vitro when engaged by BAFF 
and/or APRIL? TACI signals triggered with anti-TACI antibodies or with natural ligands 
may be different, for example because of a differential impact on TACI - proteoglycan 
interactions, which appear to modulate TACI signals 45,46. Also, it has not been 
demonstrated in vivo that TACI directly transmits negative signals within B cells: B cell 
hyperplasia in TACI-/- mice may also result from the loss of a BAFF/APRIL inhibitor 
such as a soluble, decoy form of TACI. TACI can indeed be processed at Arg122, Arg110 
TACI requires oligomerized ligands Bossen et al. Page 20 
and Lys108, and each of these cleavage events is predicted to release functional forms of 
soluble human and mouse TACI 28. Thus, loss of TACI could remove both a survival 
signal for TACI expressing cells, and an inhibitor of soluble BAFF, leading to the 
observed raise of BAFF concentration in TACI-/- mice. As a result, naïve B cells 
(expressing BAFF-R) would survive better or in greater number due to increased BAFF 
availability, leading to the observed B cell hyperplasia, whereas plasmablasts and short-
lived Ig-secreting cells that preferentially upregulate TACI and play a key role in T-
independent humoral responses 3,47 would be specifically penalized by loss of TACI.  
Interestingly, T-independent responses are inefficient in TACI-/- mice 23 and BAFF-/- mice 
20
, but not BAFF-R-/- mice 20, suggesting that they rely on a BAFF/TACI axis that, 
according to our findings, would require an oligomerized form of BAFF (60-mer or 
membrane-bound). Loss of TACI also leads to decreased IgA levels 23. In this respect, we 
can speculate that the much elevated IgA levels observed in BAFF transgenic mice 27 
may be due, at least in part, to BAFF 60-mer acting on TACI. A pro-survival role of 
TACI is also in line with its up-regulation in several multiple myeloma cell lines 48. 
Decreased plasmablast survival could contribute to decreased immunoglobulin levels in 
CVID patients with TACI mutations. Until now, impaired Ig switch has received great 
attention to explain the link between TACI-deficiency and CVID 21,25,26. Nevertheless, 
IgM levels are often reduced in these patients, indicating that defective Ig switch may not 
be the sole cause of CVID, in line with an implication of TACI in plasmablast survival.  
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Inadequate immune responses can lead to autoimmunity, and BAFF overproduction is 
consistently found in autoimmune diseases such as rheumatoid arthritis, systemic lupus 
erythematosus (SLE) or Sjögren syndrome 2. As both short-lived and long-lived Ig-
secreting cells are involved in the pathology of SLE, signaling through both TACI and 
BCMA might contribute to the disease 49. We have shown that TACI respond to 
oligomerized ligands, and it will be of interest to determine whether BAFF 60-mer may 
be produced in excess in these pathologies, and whether the specific targeting of BAFF 
60-mer may represent an alternative treatment for these autoimmune disorders. 
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Figure legends 
Figure 1: BAFF 3-mer and 60-mer bind BCMA and TACI, but only BAFF 60-mer, 
BAFF oligomers and membrane-bound BAFF activate a reporter signaling pathway 
dependent on ligand oligomerization. 
(A) Jurkat T cells expressing a BCMA:Fas chimerical receptor were exposed for 16 h to 
various concentrations of BAFF 3-mer or 60-mer. Cells were also exposed to Flag-BAFF 
(3-mer) alone or in the presence of a cross-linking anti-Flag antibody, or to Fc-BAFF (6-
mer). Cell viability was measured with the PMS/MTS assay. (B) Jurkat BCMA:Fas cells 
were incubated with varying ratio of 293T cells transfected with full-length BAFF R125A 
R126A (293T-BAFF uncleav.) or with empty plasmid (293T mock). Myc-BAFF (3-mer) 
and BAFF A134 (60-mer) were used instead of cells to calibrate the assay. BAFF present 
in transfected 293T cells was quantified by ELISA. The highest concentration used (40 
ng/ml) corresponds to an effector to target ratio of 1:1. Maximal cell death obtained with 
this assay was about 50%. (C) BAFF 3-mer and BAFF 60-mer were immunoprecipitated 
with TACI-Fc. Inputs and immunoprecipitates (IP) were analyzed by Western blotting 
using an anti-BAFF antibody (Buffy-2). The same blot was re-probed with an anti-Fc 
antibody (lower panel). The higher band of BAFF carries an N-linked oligosaccharide on 
asparagine 242, a site that is not used in mammalian cells 9. Note that recombinant TACI-
Fc is partially processed at  Lys108 and Arg110 28. (D) Recombinant BCMA-Fc, TACI-Fc 
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and BAFF-R-Fc were immobilized on ELISA plates and exposed to a fixed concentration 
of Flag-BAFF, whose binding was visualized with anti-Flag secondary reagents. BAFF 3-
mer and BAFF 60-mer were added at the indicated concentrations in order to compete 
with Flag-BAFF binding and therefore reduce the ELISA signal.  
Figure 2: Co-stimulation of thymidine incorporation in BCR-stimulated B cells by 
BAFF and APRIL is mediated by both BAFF-R and TACI. TACI responds to 
oligomerized ligands only. 
Purified B splenocytes of various genotypes were cultured under BCR-stimulating 
conditions, with or without anti-BAFF-R B9C11, and with the indicated concentrations of 
BAFF and APRIL. After 48 h, cells were pulsed for 16 h with [3H]-thymidine, harvested 
and counted.  Points represent means ± SD of triplicate cultures. Note that B9C11 
abolishes BAFF-mediated effects through BAFF-R. At the concentration used, B9C11 
totally blocked BAFF A134 at concentrations up to 10 ng/ml, but only partially at higher 
concentrations.  
Figure 3: BAFF-R- and TACI-dependent upregulation of MHC class II in B cells. 
(A) Purified wild type and TACI-/- B splenocytes were stimulated plus or minus cross-
linked APRIL in the presence of IL-4 and IL-6, and surface expression of MHC class II 
was monitored by FACS. (B) Experiment was performed as in (A) with B cells of the 
indicated genotype, and with BAFF and APRIL at the indicated concentrations.  MFI: 
mean fluorescence intensity. 
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Figure 4: Enhanced IgM secretion by splenocytes and plasmablast survival require 
TACI and oligomerized TACI ligands. 
(A) Purified B splenocytes were cultured for 6 days in the presence of 100 ng/ml of the 
indicated ligands, after which time IgM titers were measured in culture supernatants. The 
figure shows the fold increase relative to medium only for the same genotype (titers were 
comparable for the different genotypes). Results are means ± SD of triplicate cultures. (B) 
MMTV-induced plasmablasts of the indicated genotypes were purified and cultured for 
two days in the presence of 500 ng/ml of the indicated ligands or 10 ng/ml of IL-6, after 
which time IgG2a/c-secreting cells were enumerated by ELISPOT. Data are expressed as 
fold increase compared to wild type B cells in medium only, and represent means ± SD of 
triplicate (APRIL) or quadruplicate (medium and BAFF) cultures, representative of two 
experiments with similar results. (C) Tetanus toxoid-specific plasmablasts were purified 
from spleen at the peak of the booster response, and cultured for two days in the presence 
of 500 ng/l of the indicated ligands or 10 ng/ml of IL-6. Tetanus toxoid-specific 
plasmablasts were enumerated by ELISPOT, and the percentage of survival determined 
relative to values obtained at day 0. Values are mean ± SD of two independent cell 
preparations (or three preparations for wild type) cultured in triplicates. p<0.05: *. 
p<0.01: **. 
Figure 5: BAFF 60-mer is conserved across species. 
(A) Alignment of BAFF from various species, and of human TNF family members, in the 
region of the DE loop. Opossum: Monodelphis domestica (GenBank:XP_001375808) . 
Platypus: Ornithorynchus anatinus (GenBank:XP_001514753). Chicken: Gallus gallus 
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(GenBank:NM_204327). Frog: Xenopus tropicalis (EMBL:42:1929088:1912327). Fish: 
Danio rerio (GenBank: XM_684671). (B) Gel permeation chromatography analyses of 
naturally processed mouse BAFF in supernatants of 293T cells transfected with full-
length mouse BAFF. Elutions were performed at pH 7.4 or pH 5, and the elution positions 
of molecular weight standards (in kDa) are indicated at the top of the figure. Fractions 
were analyzed by western blotting using a cross-reactive anti-human BAFF antibody 
(Buffy-2). 
Figure 6: Differentially active forms of trimeric and oligomeric BAFF in mouse 
plasma. 
Plasma from BAFF transgenic, wild type and TACI-/- mice were fractionated by gel 
permeation chromatography. Mouse BAFF was quantified in the fractions by ELISA 
(black squares) and expressed with different scales for each genotype. The 
oligomerization-dependent activity of BAFF in 25 µl, 5 µl and 2.5 µl of wild type, BAFF 
transgenic and TACI-/- fractions, respectively, was detected with reporter Jurkat 
BCMA:Fas cells that die in response to oligomerized BAFF (open circles). For wild type 
and TACI-/- fractions, the assay was performed in the presence of cycloheximide (CHX) 
that enhances the sensitivity of the assay. Where indicated, BCMA-Fc was added to 
demonstrate the killing specificity (black circles). 
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Online Supplemental Material
TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of
activated B cells and plasmablasts. C. Bossen et al.
Supplemental Figure 1: Schematic representation of the different recombinant BAFF used in
the study. Recombinant BAFF were characterized previously 1.
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Supplemental Figure 2: A non-cleavable form
of full length mouse BAFF.
293T cells were transfected with full length wild
type mouse BAFF (BAFF wt) or full length
mouse BAFF with mutations R125A and R126A
in the consensus furin processing site (BAFF
uncleav.). Cells and conditioned medium were
harvested and analyzed by western blotting
using a cross-reacting anti-mouse BAFF mAb
(Buffy-2).
kDa
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Supplemental Figure 3: BAFF 60-mer is a potent activator
of BCMA-dependent NF-κB activation.
293T cells transiently co-transfected with full length human
BCMA and NF-κB reporter plasmids were stimulated with
BAFF 3-mer or 60-mer at the indicated concentrations. NF-
κB activity is shown as fold induction compared to BCMA-
transfected, but non-stimulated cells. BCMA transfection by
itself induced a 3-fold NF-κB activation compared to control
(ctrl; grey squares).
Supplemental Figure 4: BAFF promotes survival, but not proliferation, in co-stimulation
assays.
CFSE-labelled B cells were cultured for 3 days plus or minus anti-IgM, and in the presence of the
indicated ligands. Cells were analyzed by FACS (3 x 104 events). Histograms show the CFSE
profile of cells in the live lymphocyte gate.
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Supplemental Figure 5: BAFF oligomers but not BAFF 3-mer co-stimulate TACI-dependent
thymidine incorporation.
Purified wild type B splenocytes were cultured under BCR-stimulating conditions, with or
without anti-BAFF-R B9C11, and with the indicated concentrations of BAFF 3-mer and
oligomers. After 48 h, cells were pulsed for 16 h with [3H]-thymidine, harvested and counted.
Points represent means ± SD of triplicate cultures.
Supplemental Figure 6: BAFF 60-mer signaling through TACI can be inhibited by an excess
of BAFF 3-mer.
Purified BCMA-/- B splenocytes were cultured under BCR-stimulating conditions with anti-
BAFF-R B9C11, in the presence of fixed concentrations of BAFF 60-mer N242Q (0, 4, 20 or 100
ng/ml), and with the indicated concentrations of BAFF 3-mer H218A. After 48 h, cells were
pulsed for 16 h with [3H]-thymidine, harvested and counted.  The specific effect of BAFF 60-mer
is shown (Specific effect of BAFF 60-mer = thymidine incorporation with BAFF 60-mer -
thymidine incorporation without BAFF 60-mer. Thymidine incorporation without BAFF 60-mer
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varied form 13 to 15 x 103 cpm). Points represent means ± SD of triplicate cultures. Similar
results were obtained with wild type B cells (data not shown).
Supplemental Figure 7: BAFF oligomers but not BAFF 3-mer signal MHC class II
upregulation in a TACI-dependent manner.
(A) Purified wild type B splenocytes were stimulated with the indicated BAFF preparations and
surface expression of MHC class II was monitored by FACS. MFI: mean fluorescence intensity.
This experiment was performed in the absence of IL4 and IL6.
Supplemental Figure 8: Enhanced sensitivity of multimeric BAFF detection using
cycloheximide and Jurkat BCMA:Fas cells.
Jurkat BCMA:Fas cells were incubated with the indicated volume of plasma from BAFF
transgenic mice, in a final volume of 50 µl, and in the presence or absence of 1.5 µg/ml of
cycloheximide and of 2.5 µg/ml of BCMA-Fc. Cell viability was measured after 16 h incubation
with the PMS/MTS assay.
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Supplemental methods.
Cells and reagents
293T cells were grown in DMEM
supplemented with 10% FCS and 0.1%
Na2CO3. Jurkat-BCMA:Fas cells (Jurkat-
2309 clone 13) were cultured in RPMI, 10%
FCS. Primary mouse B cells were cultured
in RPMI, 10% FCS, 50 µM 2-
mercaptoethanol, 5 µg/ml each penicillin
and streptomycin (complete RPMI).
Generation of Jurkat-BCMA:Fas cells
Retroviruses were produced essentially as
described previously 2. Briefly, 293T cells
were transiently transfected with
pMSCVpuro-BCMA:Fas and co-transfected
with the pHIT60 and VSV-G plasmids,
containing the sequences for gag-pol and
VSV-G, respect ively.  pMSCVpuro-
BCMA:Fas encodes the signal peptide of
haemaglutinin, a linker (VQCEVKLPRGS),
the extracellular domain of human BCMA
(amino acids 2-54), amino acids VD and the
transmembrane and intracellular domains of
human Fas (amino acids 169-335). After
transfection, 293T cells were incubated for
24 h in RPMI supplemented with 10% FCS.
Jurkat cells (106 cells in 1 ml) were mixed
with virus-containing supernatants (3 ml)
supplemented with 8 µg/ml of polybrene,
left for 15 min at 37°C, and centrifuged for
1 h at 37°C and at 450 x g (1500 rpm). Cells
were selected with 5 µg/ml of puromycin
and cloned. About 40 clones were tested for
their sensitivity to Fc-BAFF 3, and one of
the sensitive clones (Jurkat-2309 clone 13)
was selected for further experimentation.
Production of Flag-tagged APRIL.
Flag-tagged APRIL containing amino acids
92-233 of human APRIL was purified from
supernatants of transiently transfected 293T
cells using anti-Flag M2-agarose (Sigma).
Flag-APRIL was eluted with citrate-NaOH
pH 3 and neutralized with Tris-HCl pH 9.
Buffer was exchanged for PBS, and the
protein was stored at -70°C until use.
Immunoprecipitations:
1 µg of TACI:Fc comprising amino acids 2-
118 of hTACI 4 was mixed with 250 ng of
various BAFF preparations in 1 ml of PBS,
immunoprecipitated with Protein A-
Sepharose (GE Healthcare), and analyzed by
western blotting with Buffy-2 mAb (rat IgM
anti-human BAFF). The membrane was
reprobed with horseradish peroxidase-
coupled goat anti-human antibodies
(Jackson ImmunoResearch).
Competition ELISA:
ELISA plates were coated for 16 h at room
temperature with 5 µg/ml of mouse anti-
human IgG (Fc)gamma fragment-specific
antibody (Jackson Immunoresearch) in 50 µl
of 50 mM NaHCO3-NaOH, pH 9.6. Plates
were blocked with PBS, 4% skimmed milk,
0.5% Tween-20 (block buffer). Subsequent
incubations were done in 50µl of PBS, 0.4%
skimmed milk, 0.05% Tween-20 (incubation
buffer). 20 µl of cell supernatants containing
BCMA-Fc (amino acids 2-54 of hBCMA) or
TACI-Fc (amino acids 2-118 of hTACI)
(about 50 ng) were added, followed by a
fixed, optimized amount of Flag-BAFF
(amino acids 137-285 of hBAFF) in cell
supernatant to yield a maximal but non-
saturating signal (about 50 ng/ml), in the
presence of the indicated concentration of
various BAFF preparations used as
competitors. Binding of Flag-BAFF was
revealed with biotinylated anti-Flag M2 (0.5
µg/ml) (Sigma), followed by horseradish
peroxydase-conjugated streptavidin (Jackson
I m m u n o R e s e a r c h )  a n d  o r t h o -
phenylenediamine / H2O2 reagents (Sigma).
Absorbance was measured at 492 nm with
an ELISA reader.
Plasma collection:
200 µl of mouse blood was collected on 2 µl
of 0.5 M Na-EDTA pH 8 and 2 µl of 10%
NaHCO3 pH 9.8, followed by centrifugation
for 3 min at room temperature and at 2000 x
g. Buffered plasma was stored frozen (or at
4°C for up to three days).
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ELISA for mouse BAFF:
ELISA plates were coated for 16 h with 100
µl of 3 µg/ml of rat IgG1 anti-mouse BAFF
5A8 in PBS, blocked for 2 h with block
buffer, washed and incubated for 3 h at
room temperature with mouse BAFF-
containing samples (150 µl or 15 µl of 1 ml
Superdex fractions), or known concentration
of mouse BAFF standard. Bound BAFF was
revealed with 100 µl of biotinylated rat IgG1
anti-mouse BAFF 1C9 at 2 µg/ml for 2 h in
incubation buffer, followed by horseradish
peroxidase-coupled streptavidin (1:4000, 1h;
Jackson ImmunoResearch). Peroxydase
activity was measured at 492 nm with ortho-
phenylenediamine reagent.
ELISA for IgM and IgA:
ELISA plates were coated for 16 h with 2
µg/ml of goat anti-mouse IgA (Caltag) or
goat anti-mouse IgG + M (Caltag) in 50 mM
of sodium carbonate buffer pH 9.6, blocked
with block buffer, washed and incubated
with cell culture supernatants (1:2 and
threefold dilutions in incubation buffer) or
known concentration of mouse IgM standard
(Ancell). Bound antibodies were revealed
with biotinylated goat anti-mouse IgA
(1:2000, Caltag) or biotinylated goat anti-
mouse  IgM (1 :2000 ,  J ackson
ImmunoResearch) followed by horseradish
peroxidase-coupled streptavidin (1:4000;
Jackson ImmunoResearch). Peroxydase
activity was measured at 492 nm with ortho-
phenylenediamine reagent.
ELISPOT:
ELISA plates were coated for 16 h with 50
µl of goat anti-mouse IgG + M (2 µg/ml;
Caltag) in 50mM of sodium carbonate buffer
pH 9.6, blocked for 2 h at 37°C with 300 µl
of PBS + 1% BSA, washed and incubated
for 6 hours at 37°C with the cell cultures
(1:2 and 2-fold serial dilutions in complete
RPMI), taking care not to move cells during
incubation. Plates were washed. For
MMTV-induced plasmablasts, spots were
revealed with biotinylated goat anti-mouse
IgG2a/c (1:1000 in PBS, 0.025% Tween-20,
Caltag). For bone marrow plasma cells,
spots were revealed with biotinylated goat
anti-mouse IgG (Jackson ImmunoResearch).
Biotinylated antibodies were revealed with
alkaline phosphatase-coupled streptavidin
(1:1000; Jackson ImmunoResearch) and
finally by 5-bromo-4-chloro-3-indolyl
phosphate / nitroblue tetrazolium (NCIP/
NBT) solution (Sigma).
For tetanus toxoid-specific plasmablasts,
MULTIscreen HA plates (Millipore) were
coated with 50µl of tetanus toxoid (10µg/ml
in PBS) for 16h at 37°C, blocked for 1 h at
37°C with 200µl of RPMI, 10% FCS,
washed and incubated for 5 hours at 37°C
with the cell cultures (1:2 and 2-fold serial
dilutions in complete RPMI), taking care not
to move cells during incubation. After
washing, spots were revealed with
peroxydase-coupled goat anti-mouse IgG
(1:1000 in PBS, 0.025% Tween-20, Zymed)
and finally by 3-amino-9-ethyl carbazole
(Sigma) in dimethylformamid (Sigma).
Survival assay for tetanus toxoid-specific
plasmablasts
Mice of the various genotypes were mice
immunized intraperitoneally with alum-
adsorbed tetanus toxoid (1 Lf per mice) in
the presence of CpG1826 (50 µg) 5. CpG1826 is
required to obtain efficient responses in the
C57/Bl6 background. Mice were boosted 5
weeks post-immuniziation with 1 Lf of
tetanus toxoid (in alum), and spleen were
harvested 4 days later, at the peak of the
booster response. CD138+ splenic
plasmablasts were purified with PE-
conjugated anti-mouse CD138 (Becton
Dickinson) and anti-PE magnetic beads
(Miltenyi Biotech). Purified plasmablasts
(5x104/well in 200 µl of complete RPMI
containing only 1.4 % FCS) were incubated
for 44 hours with different ligands at 500
ng/ml or IL-6 at 10 ng/ml. Number of viable
plasmablasts were analyzed at day 0 and day
2 by tetanus toxoid-specific ELISPOT 6.
NF-κB reporter assay:
NF-κB assays were performed essentially as
described 7. 293T cells were seeded
overnight in 96 well plates in 100 µl of
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DMEM, 10% FCS. Cells were transfected
using PolyFect transfection reagent (Qiagen)
with 70 ng/well of a plasmid mix containing
a NF-κB luciferase reporter plasmid (7.5
ng), a renilla luciferase plasmid for
normalization (7.5 ng), an EGFP tracer
plasmid (7.5 ng), a plasmid encoding full
length hBCMA (20 ng) and an empty
plasmid (22.5 ng). 8 h later, medium was
exchanged for fresh DMEM supplemented
with 10% FCS and the indicated
concentration of myc-BAFF (3-mer) or
BAFF A134 (60-mer). After 24 h, cells were
lyzed and firefly and renilla luciferase
activities were quantified with dual
luciferase reporter assay system (Promega)
and a TopCount-NTX luminometer
(Packard).
Splenocyte co-stimulation assay:
Splenic B cells were isolated with anti-B220
magnetic beads according to the provider's
instructions (Miltenyi Biotech). Purified B
cells (3x105/well in 200 µl of complete
RPMI) were grown for 48 h with 2 µg/ml of
goat F(ab')2 anti-mouse µ chain antibody
(Jackson ImmunoResearch) and in the
presence of serial dilutions of various
ligands. Where indicated, BAFF 3-mer was
added as a competitor for BAFF 60-mer.
When required, anti-Flag M2 antibody (1
µg/ml) or anti-BAFF-R B9C11 (0.5 µg/ml)
were added. Cells were pulsed for an
additional 16-18 h with 1 µCi/well of
tritiated thymidine, harvested and counted in
a TopCount-NTX liquid scintillation counter
(Packard).
In some experiments, purified B cells at 106
cells/ml were stained for 10 min at 37°C
with CFSE at 1 µg/ml in PBS prior to
cultivation. These cells were analyzed using
a three-color FACScan flow cytometer
(Becton Dickinson, San Jose, CA) and
FlowJo software (Tree Star, Inc.). Viable
cells were differentiated from dead cells by
the FSC/SSC profile.
MHC class II upregulation assay:
Purified splenic B cells (3x105/well in 200
µl of complete RPMI, supplemented or not
with 0.2 ng/ml each IL-4 and IL-6) were
grown for 66 h in the presence of the
indicated ligands, stained with FITC-
conjugated anti-mouse MHC class II Ia+Ie
(Becton Dickinson) and analyzed by FACS.
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